Dominik R Berthold

6PUBLICATIONS
83CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 18, 2026
[Intensification of radio-hormone therapy for prostate cancer].

|Apr 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.

|Aug 05, 2025
Correction: Cloître et al. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study. <i>Cancers</i> 2024, <i>16</i>, 2097.

Minna Cloître, Sofian Benkhaled, Sarah Boughdad

|Jun 19, 2024
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study.

Minna Cloître, Sofian Benkhaled, Sarah Boughdad

|Apr 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).

Nicholas D James, Noel W Clarke, Adrian Cook

|Sep 04, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.

Fernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza

Pageof 1

Frequent Collaborators

4 joint publications

John Prior

4 joint publications

Fernanda Herrera

2 joint publications

Sofian Benkhaled

2 joint publications

Michele Zeverino